ELCO Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,400
Closed -$267K 147
2018
Q3
$267K Hold
1,400
0.14% 119
2018
Q2
$233K Buy
1,400
+5
+0.4% +$803 0.13% 125
2018
Q1
$235K Sell
1,395
-15
-1% -$2.52K 0.14% 123
2017
Q4
$231K Sell
1,410
-722
-34% -$130K 0.13% 134
2017
Q3
$437K Hold
2,132
0.25% 100
2017
Q2
$518K Buy
2,132
+60
+3% +$14.1K 0.3% 88
2017
Q1
$495K Buy
2,072
+225
+12% +$52.4K 0.26% 90
2016
Q4
$388K Sell
1,847
-4,648
-72% -$963K 0.22% 104
2016
Q3
$1.5M Buy
+6,495
New +$1.59M 0.6% 48

Other funds holding AGN

ELCO Management's AGN Position: Q4 2018 in Review

ELCO Management sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 1,400 shares — an estimated $267K sold.

ELCO Management first reported a position in AGN in Q3 2016 and held it in 9 quarters. The position peaked at $1.5M in Q3 2016. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • ELCO Management reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • ELCO Management sold 1,400 Allergan plc shares in Q4 2018, an estimated $267K.
  • ELCO Management first reported a position in Allergan plc in Q3 2016 and held it in 9 quarters.
  • ELCO Management's Allergan plc position peaked at $1.5M in Q3 2016.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on ELCO Management's 13F filing for Q4 2018, filed 14 Feb 2019.